期刊文献+

pSG5/NS5A5BΔC质粒的构建及在Huh7细胞中的表达 被引量:3

Construction of pSG5/NS5A5BΔC and its expression in Huh7 cells
原文传递
导出
摘要 目的:构建pSG5/NS5A5B△C质粒,并检验其在Huh7细胞中的瞬时表达。方法:使用已经构建的pTM1-NS2NS5A5B△C质粒为模板,根据pTM1、HCV NS5A5B△C、pSG5序列和酶切位点特点设计引物,PCR扩增得到HCVNS5A5B△C基因片段,将目的片段插入pSG5载体中,经筛选阳性克隆、SacⅠ和BglⅡ分别酶切鉴定后,用FuGene6转染试剂转染入Huh7细胞。用免疫荧光染色、Western blot检测HCV NS5A5B△C在Huh-7细胞中的表达。结果:限制性内切酶SacⅠ和BglⅡ分别酶切鉴定后,琼脂糖凝胶电泳结果显示酶切片段大小和插入方向均与预计一致。荧光显微镜下可见转染的Huh7细胞表达带有绿色荧光的HCV NS5A5B△C蛋白,该蛋白主要表达于细胞质,表达率达40%以上。West-ern blot结果也证实在转染pSG5/NS5A5B△C的Huh7细胞中出现了大小与HCV NS5A5B△C(82ku)一致的条带。结论:成功构建了pSG5/NS5A5B△C质粒,并在Huh7细胞中成功瞬时表达,为进一步研究HCV蛋白的功能奠定了基础。 AIM: To construct the plasmid pSG5/NS5A5B△C, and to investigate its expression in Huh7 ceils. METHODS: The plasmid pTM1-NS2 NS5A5B△C was taken as the template. The primers were designed according to the characteristics of the sequence and endoenzyme cleavage sites in HCV NS5A5B△C and vector pTM1, pSGS. The HCV NS5A5B△C gene fragment was amplified by PCR from pTM1-NS2NS5ASB△C and inserted into vector pSGS. The positive clones were screened by Ampicillin and identified by the restriction endoenzyme Sac Ⅰ and Bgl Ⅱ digestion and agarose gel electrophoresis. The constructs were transfected into Huh7 cells with FuGene 6 reagents. Immunofluorescence and Western blot were performed to detect the expression of the constructs in Huh7 cells. RESULTS: Endoenzyme digestion analysis showed that the size and the inserting orientation of the fragment met the design expectation. Immunofluorescence staining displayed the expression of HCV NS5A5B△C protein, which was located in the cytoplasm, and the expression rate reached as high as 40%. SDS-PAGE analysis showed that the relative molecular mass of the expressed product by pSG5/NS5A5B△C was about 82 ku, which was consistent with the theoretical value. CONCLUSION: pSG5/NS5A5B△C is successfully constructed, and it can be expressed transiently in Huh7 cells, which would lay a foundation for the further study on function of HCV poiyprotein.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第1期31-34,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 日中笹川医学奖学金资助项目(2006~2007年)
关键词 丙型肝炎病毒 非结构蛋白5A5B pSG5 HUH7细胞 hepatitis C virus NS5ASB pSGS Huh7 ceils
  • 相关文献

参考文献10

  • 1Grakoui A, McCourt D W, Wychowski C, et al. Characterization of the hepatitis C virus-encoded serine proteinase : detemination of proteinasedepended polyprotein cleavage sites[J]. J Virol, 1993, 67: 2832.
  • 2Bartenschlager R, Ahlbom-Laake L, Mous J, et al. Kinetic and structural analyses of hepatitis C virus polyprotein processing[ J]. J Virol, 1994, 68 : 5045 -5055.
  • 3Lin C, Pragai BM, Grakoui A, et al. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics [ J ]. J Virol, 1994, 68:8147-8157.
  • 4Tanaka M, Nagano-Fujii M, Deng L, et al. Single-point mutations of hepatitis C virus NS3 that impair p53 interaction and anti-apoptotic activity of NS3[J]. Biochem Biophys Res Com, 2006, 340:792-799.
  • 5Merkinaite S, Lazarus JV, Gore C. Addressing HCV infection in Europe: reported, estimated and undiagnosed cases [ J ]. Cent Eur J Public Health, 2008, 16:106 -110.
  • 6Freundt EC, Lenardo MJ. Interfering with interferons: Hepatitis C virus counters innate immunity [ J]. PNAS, 2005, 102:17539 - 17540.
  • 7Greene WK, Cheong MK, Ng V, et al. Prevalence of hepatitis C virus sequence variants in South-East Asia[ J]. J Gen Virol, 1995,76:211 -215.
  • 8Hotta H, Kemapunroanus M, Apichartpiyakul C, et al. Differential distribution of hepatitis C virus subgroups in Asia: comparative study among Thailand, Indonesia, the Philippines and Japan[ J]. Southeast Asian J Trop Med Public Health, 1997, 28:323 -331.
  • 9Ogata S, Florese R H, Nagano-Fujii M, et al. Identification of hepatitis C virus (HCV) subgroup 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein [J]. J Clin Microbiol, 2003, 41 : 2835 -2841.
  • 10Deng L, Nagano-Fujii M, Tanaka M, et al. NS3 protein of hepatitis C virus associates with the tumor suppressor p53 and inhibits its function in an NS3 sequence-dependent manner[J]. J Gen Virol, 2006, 87 : 1703 - 1713.

同被引文献20

  • 1Doi H, Apiehartpiyakul C, Ohba KI, et al. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subgroups of HCV major type 6. J Clin Microbiol, 1996, 34: 569-574.
  • 2Mellor J, Holmes EC, Jarvis LM, et al. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Virol, 1995, 76 (Pt10) : 2493-2507.
  • 3Robertson B, Myers G, Howard C, et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related virus: proposals for standardization. Arch Virol, 1998, 143: 2493-2503.
  • 4Davidson F, Simmonds P, Fergason JC, et al. Survey of major genotypes and subgroups of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol, 1995, 76 (Pt 5) : 1197-1204.
  • 5Greene WK, Cheong MK, Ng V, et al. Prevalence of hepatitis C virus sequence variants in South-East Asia..I Gen Virol, 1995, 76: 211-215.
  • 6Ogata S, Florese RH, Nagano-Fujii M, et al. Identification of hepatitis C virus (HCV) subtype lb strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein. J Clin Mierobiol, 2003, 41 : 2835-2841.
  • 7Deng L, Nagano-Fujii M, Tanaka M, et al. NS3 protein of hepatitis C virus associates with the tumor suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J Gen Virol, 2006, 87(Pt6) : 1703-1713.
  • 8Tanaka M, Nagano-Fujii M, Deng L, et al. Single-point mutations of hepatitis C virus NS3 that impair p53 interaction and anti-apoptotic activity of NS3. Biochem Biophys Res Com, 2006, 340 : 792-799.
  • 9Kadoya H, Nagano-Fujii M, Deng L, et al. Nonstructural proteins 4A and gB of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol Immunol, 2005,49:265-273.
  • 10Breiman A, Grandvaux N, Lin R, et al. Inhibition of RIG-I- Dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKε. J Virol, 2005,79 : 3969-3978.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部